Back

Abbott to Acquire Exact Sciences in $23 Billion Deal

The US-based healthcare company aims to strengthen its diagnostics portfolio through the planned purchase of cancer testing firm Exact Sciences.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Diagnostics portfolio: The range of medical testing products and services a company offers to detect and monitor diseases.
  • Cancer testing: Medical tests designed to detect the presence or progression of cancer in patients.